Table 2.
Patient ID | Sample | JCV subtypea | PML-associated substitution | No. of clones with substitution/no. of clones analyzed | |
1 | 5067 | Urine | 1A | none | 0/11 |
5067 | CSF | 1A | H122R | 27/27 | |
5067 | Plasma | 1A | H122R | 28/28 | |
2 | 5167 | Urine | 2B-v69D,128A | none | 0/23 |
5167 | CSF | 2B-v69D,128A | S267Y | PCRb | |
5167 | Plasma | 2B-v69D,128A | S267Y | 42/44 | |
3 | 5166 | Urine | 1A | none | 0/29 |
5166 | CSF | 1A | S269F | 14/14 | |
5166 | Plasma | 1A | S269Fc | 18/21 | |
4 | 5174 | Urine | 1B | none | 0/19 |
5174 | CSF | 1B | S269F | 28/28 | |
5174 | Plasma | 1B | S269F | 37/38 | |
5 | 5180 | Urine | 1A | none | PCR |
5180 | CSF | 1A | S269F | PCR | |
5180 | Plasma | 1A | S269F | PCR | |
6 | 5211 | Urine | 2B | none | PCR |
5211 | CSF | 2B | none | PCR | |
5211 | Plasma | N | NA | NA | |
7 | 5087 | Urine | 1B | none | 0/11 |
5087 | CSF | 1B | L55F | 19/19 | |
5087 | Plasma | NA | NA | NA | |
8 | 5152 | Urine | 1A | none | 0/3 |
5152 | CSF | 1A | H122R; A2V | 44/46; 45/46 | |
5152 | Plasma | NA | NA | NA | |
9 | 5088 | Urine | NA | NA | NA |
5088 | CSF | 4-v164K | none | 0/3 | |
5088 | Plasma | 4-v164K | none | 0/24 | |
10 | 5092 | Urine | NA | NA | NA |
5092 | CSF | 1A | L55F | 20/20 | |
5092 | Plasma | 1A | L55F | PCR | |
11 | 5108 | Urine | NA | NA | NA |
5108 | CSF | 4-v128A,345K | L55F | 24/24 | |
5108 | Plasma | 4-v128A,345K | L55F | 30/30 | |
12 | 5201 | Urine | NA | NA | NA |
5201 | CSF | 1B | K60N | PCR | |
5201 | Plasma | 1B | K60N | PCR | |
13 | 5029 | Urine | NA | NA | NA |
5029 | CSF | 2B-v74T,345K | S269F | 21/22 | |
5029 | Plasma | 2B-v74T,345K | S269F | 19/19 | |
14 | 5060 | Urine | NA | NA | NA |
5060 | CSF | 2B | S269F | 23/23 | |
5060 | Plasma | 2B | S269F | 31/31 | |
15 | 5121 | Urine | NA | NA | NA |
5121 | CSF | 1B-v117T | S269F | 41/41 | |
5121 | Plasma | 1B-v117T | S269F | 12/12 | |
16 | 5207 | Urine | NA | NA | NA |
5207 | CSF | 1B | Q271H | PCR | |
5207 | Plasma | 1B | Q271H | PCR | |
17 | 5163 | Urine | 4-v164K | none | 0/24 |
5163 | CSF | NA | NA | NA | |
5163 | Plasma | 4-v164K | L55Fd | 32/32 |
NOTE. JCV indicates JC virus; VP1, viral protein 1; PML, progressive multifocal leukoencephalopathy; PCR, polymerase chain reaction; NA, sequence not available.
According to [8]. The subgroup, followed by āvā and position, means subgroup variant and polymorphism relative to that subtype.
PCR sequence information was obtained directly from a PCR product without cloning.
S267F also identified in 3/21 clones.
S267P also identified in 2/32 clones.